Nuvectis Pharma, Inc. — Director's Dealing 2023

Jan 13, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Nuvectis Pharma, Inc. (NVCT)
CIK: 0001875558
Period of Report: 2023-01-12

Reporting Person: BENTSUR RON (Director, Chairman & CEO, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-01-12	Common Stock	A	210000	—	Acquired	3225459	Direct

Footnotes

F1: The restricted stock units will vest according to the following schedule: one-third on each of 01/12/2024, 01/12/2025, and 01/12/2026.

F2: Includes 96,759 shares of restricted stock and 330,000 restricted stock units.